Molecular Characterization of Gliomas Using a Broad NGS Panel
Molecular Characterization of Gliomas Using a Broad NGS Panel
Gliomas are the most common malignant primary brain tumors with poor prognosis. The genotyping of tumors using NGS platforms enables the identification of genetic alterations that constitute diagnostic, prognostic and predictive biomarkers.Here in, we investigated the molecular profile of 32 tumor samples from 32 patients with high grade gliomas by implementing a broad 80-gene targeted NGS panel while reporting their clinicopathological characteristics and outcomes.
Inclusion Criteria:
Diagnosis of high grade glioma based on tissue biopsy
Exclusion Criteria: